晨光生物业绩快报：2025年净利润3.64亿元 同比增长286.65%

Core Insights - The company reported a significant increase in revenue and profits for the fiscal year 2025, with total revenue reaching 6.564 billion yuan and net profit attributable to shareholders at 364 million yuan, marking year-on-year growth of 286.65% [1] - The growth in financial metrics was primarily driven by the revenue and gross profit increase in the plant extraction business, while the cottonseed business saw a decrease in trade volume but managed to turn a profit due to improved product margins [1] Financial Performance - In 2025, the company achieved a total revenue of 6.564 billion yuan, with operating profit and total profit increasing by 313.92% and 311.82% year-on-year, respectively [1] - The net profit attributable to shareholders reached 364 million yuan, reflecting a year-on-year increase of 286.65% [1] - The net profit after deducting non-recurring gains and losses and basic earnings per share saw year-on-year growth of 595.83% and 320.30%, respectively [1] Product Performance - The main product, chili red, sold 12,000 tons, representing a year-on-year increase of approximately 27%, while chili extract sales reached 2,900 tons, up 65% year-on-year, both achieving historical sales highs [2] - The customized products in chili red and chili extract saw significant growth, with sales increasing by 76% and 171% year-on-year, respectively [2] - The stevia sugar business achieved a historical sales revenue of 280 million yuan, supported by continuous product system improvements and optimized customer structure [2] - The silymarin extract sales exceeded 700 tons, marking a 66% year-on-year increase, contributing to the company's portfolio of leading global products [2] - The subsidiary Xinjiang Chenguang Protein processed nearly 1 million tons of cottonseed, generating approximately 2.9 billion yuan in revenue and successfully turning a profit [2]